Raymond James & Associates Bio Techne Corp Transaction History

Raymond James & Associates

$161 Billion
Q3 2024

A detailed history of Raymond James & Associates transactions in Bio Techne Corp stock. As of the latest transaction made, Raymond James & Associates holds 356,597 shares of TECH stock, worth $20.9 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

356,597

Previous 348,140 2.43%

Holding current value

$20.9 Million

Previous $24.9 Million 14.24%

% of portfolio

0.02%

Previous 0.02%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	BUY	$70.96 - $82.35 $600,108 - $696,433	8,457 Added 2.43%	356,597 $28.5 Million
Q2 2024 Jul 19, 2024	BUY	$62.12 - $84.15 $866,760 - $1.17 Million	13,953 Added 4.18%	348,140 $24.9 Million
Q1 2024 Apr 22, 2024	BUY	$65.98 - $77.09 $2.36 Million - $2.75 Million	35,698 Added 11.96%	334,187 $23.5 Million
Q4 2023 Jan 16, 2024	BUY	$52.83 - $78.22 $2.22 Million - $3.28 Million	41,929 Added 16.34%	298,489 $23 Million
Q3 2023 Oct 24, 2023	BUY	$67.52 - $89.42 $1.59 Million - $2.11 Million	23,564 Added 10.11%	256,560 $17.5 Million
Q2 2023 Jul 25, 2023	BUY	$73.76 - $85.98 $634,040 - $739,084	8,596 Added 3.83%	232,996 $19 Million
Q1 2023 Apr 14, 2023	BUY	$71.62 - $86.62 $2.13 Million - $2.58 Million	29,740 Added 15.28%	224,400 $16.6 Million
Q4 2022 Feb 08, 2023	BUY	$80.67 - $352.29 $11.7 Million - $51.1 Million	145,152 Added 293.19%	194,660 $16.1 Million
Q3 2022 Oct 25, 2022	BUY	$282.54 - $391.85 $1.19 Million - $1.64 Million	4,198 Added 9.27%	49,508 $14.1 Million
Q2 2022 Aug 12, 2022	SELL	$322.67 - $449.65 $131,972 - $183,906	-409 Reduced 0.89%	45,310 $15.7 Million
Q1 2022 May 11, 2022	SELL	$353.85 - $487.79 $501,405 - $691,198	-1,417 Reduced 3.01%	45,719 $19.8 Million
Q4 2021 Feb 08, 2022	SELL	$456.15 - $525.06 $2 Million - $2.3 Million	-4,385 Reduced 8.51%	47,136 $24.4 Million
Q3 2021 Nov 02, 2021	SELL	$444.87 - $538.88 $1.82 Million - $2.2 Million	-4,090 Reduced 7.35%	51,521 $25 Million
Q2 2021 Aug 11, 2021	SELL	$387.35 - $450.26 $300,970 - $349,852	-777 Reduced 1.38%	55,611 $25 Million
Q1 2021 May 14, 2021	BUY	$314.62 - $411.0 $1.5 Million - $1.96 Million	4,771 Added 9.24%	56,388 $21.5 Million
Q4 2020 Feb 12, 2021	BUY	$246.9 - $321.87 $1.19 Million - $1.55 Million	4,829 Added 10.32%	51,617 $16.4 Million
Q3 2020 Nov 04, 2020	BUY	$232.22 - $282.96 $1.6 Million - $1.95 Million	6,892 Added 17.27%	46,788 $11.6 Million
Q2 2020 Jul 28, 2020	SELL	$185.43 - $279.56 $283,337 - $427,167	-1,528 Reduced 3.69%	39,896 $10.5 Million
Q1 2020 Apr 21, 2020	BUY	$161.17 - $221.51 $1.65 Million - $2.26 Million	10,212 Added 32.72%	41,424 $7.86 Million
Q4 2019 Feb 12, 2020	BUY	$189.68 - $222.09 $848,818 - $993,852	4,475 Added 16.74%	31,212 $6.85 Million
Q3 2019 Nov 07, 2019	BUY	$183.56 - $216.72 $529,203 - $624,803	2,883 Added 12.09%	26,737 $5.23 Million
Q2 2019 Aug 06, 2019	BUY	$188.72 - $215.43 $2,830 - $3,231	15 Added 0.06%	23,854 $4.97 Million
Q1 2019 May 06, 2019	SELL	$136.09 - $200.44 $108,735 - $160,151	-799 Reduced 3.24%	23,839 $4.73 Million
Q4 2018 Feb 11, 2019	SELL	$132.75 - $203.8 $89,340 - $137,157	-673 Reduced 2.66%	24,638 $3.57 Million
Q3 2018 Nov 14, 2018	BUY	$147.44 - $204.11 $56,764 - $78,582	385 Added 1.54%	25,311 $5.17 Million
Q2 2018 Aug 14, 2018	BUY	$144.9 - $165.58 $1.54 Million - $1.75 Million	10,595 Added 73.93%	24,926 $3.69 Million
Q1 2018 May 14, 2018	BUY	$131.46 - $151.04 $22,874 - $26,280	174 Added 1.23%	14,331 $2.17 Million
Q4 2017 Feb 14, 2018	BUY	$121.17 - $134.75 $37,562 - $41,772	310 Added 2.24%	14,157 $1.83 Million
Q3 2017 Nov 13, 2017	BUY	$113.59 - $123.78 $420,850 - $458,604	3,705 Added 36.53%	13,847 $1.67 Million
Q2 2017 Aug 14, 2017	BUY	N/A	10,142	10,142 $1.19 Million

Others Institutions Holding TECH

# of Institutions

614

Shares Held

161M

Call Options Held

225K

Put Options Held

80.8K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.3B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account

Raymond James & Associates Bio Techne Corp Transaction History